The comparative effectiveness of partial nephrectomy versus radical nephrectomy to preserve kidney function has not been well established. We determined the risk of clinically significant (stage 4 and higher) CKD after radical or partial nephrectomy among veterans treated for kidney cancer in the Veterans Health Administration (2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010)(2011)(2012)(2013). Among patients with preoperative eGFR$30 ml/min per 1.73 m 2 , the incidence of CKD stage 4 or higher after radical (n=9759) or partial nephrectomy (n=4370) was 7.9% overall.
is increasing concern that surgically induced CKD will be associated with an increased risk of hospitalization, cardiovascular events, and death, as has been shown in CKD from all causes. [7] [8] [9] [10] Furthermore, CKD is independently associated with postoperative death and cardiovascular events in patients undergoing elective noncardiac surgery. 11 Consequently, partial nephrectomy has been increasingly adopted in order to minimize surgically induced CKD and is now considered a standard surgical approach for early-stage kidney cancer. 12, 13 The Veterans Health Administration (VHA) is the largest integrated national health care system in the United States. Veterans treated in the VHA tend to be older and sicker than patients treated in the community and, as a result, may be more sensitive to changes in kidney function after kidney surgery. 14, 15 We have previously shown that the use of partial nephrectomy in the VHA has been increasing in parallel with the rest of the country. 16 We sought to determine the postoperative change in kidney function among patients undergoing radical or partial nephrectomy in the VHA. We hypothesized that partial nephrectomy would better preserve kidney function when compared with radical nephrectomy after accounting for preoperative kidney function and relevant patient, clinical, and tumor factors.
RESULTS
In the full cohort (n=14,129), a total of 1121 (7.9%) patients experienced incident stage 4 or higher CKD, including 183 patients after partial nephrectomy and 938 patients after radical nephrectomy. Kaplan-Meier plots demonstrate the freedom from stage 4 or higher CKD for all patients and from stage 3b or higher CKD for patients with normal or near-normal preoperative kidney function (Figure 1 ). For patients experiencing a kidney function outcome, most (75%) occurred within the first 9 months after surgery, with a median time from surgery of 5 months (25th, 75th percentile, 4-8 months). In the full cohort, the average postoperative eGFR measurements declined slowly after partial nephrectomy (20.41 ml/min per 1.73 m 2 per year), and increased slightly after radical nephrectomy (0.25 ml/min per 1.73 m 2 per year) ( Figure 2, Supplemental Figure 1 ). The unadjusted patient demographics of the full cohort are included in Supplemental Table 1 .
Preoperative kidney function was inversely associated with the development of clinically significant CKD, whereas older age at the time of surgery was directly associated with the development of clinically significant CKD. Similarly, preoperative kidney function and patient age were associated with the development of stage 3b or greater CKD for patients with normal or near-normal preoperative kidney function (Supplemental Figures 2 and 3 ). Patients with larger tumors (T2) treated with partial nephrectomy did show increased incidence of clinically significant postoperative CKD when compared with patients with T1 tumors (Supplemental Figure 4) .
Propensity Score-Matched Cohorts
Propensity score matching balanced important patient characteristics (Supplemental Table 2, Table 1 ). Similar to the full cohort, among patients in the propensity score-matched cohorts, 83 patients (2.8%) experienced incident stage 4 or higher CKD after partial nephrectomy compared with 212 patients (7.2%) after radical nephrectomy. In the propensity score-matched cohort with normal or near-normal kidney function, 62 patients (3.4%) developed stage 3b or higher CKD compared with 354 (19.2%) patients after radical nephrectomy ( Figure 3) .
In propensity score-matched cohorts, the relative hazard (partial versus radical nephrectomy) of incident CKD stage 4 or higher was significantly reduced (0.34; 95% confidence interval [95% CI], 0.26 to 0.43) ( Table 2 ). The association remained after controlling for tumor stage (0.28; 95% CI, 0.18 to 0.43) (Supplemental Table 3 ). Among patients with normal or near-normal kidney function, the relative hazard of incident CKD stage 3b or higher was also significantly reduced (0.15; 95% CI, 0.11 to 0.19); this association was unchanged after further adjustment for tumor stage (0.13; 95% CI, 0.08 to 0.20).
Competing Risks Analysis
The adjusted competing risks regression model is shown in Supplemental Table 4 . More patients in the propensity scorematched cohort died (n=1107, 18.7%) than experienced clinically significant CKD (n=295, 5.0%). Partial nephrectomy was independently associated with a lower relative hazard of CKD in the propensity score-matched cohort (subdistribution relative hazard, 0.36; 95% CI, 0.28 to 0.47). This association was preserved when controlling for tumor T stage (0.28; 95% CI, 0.18 to 0.44). Among propensity score-matched patients with normal or nearnormal preoperative kidney function, 502 patients (13.6%) died whereas 416 (11.3%) experienced decline in kidney function to eGFR,45 ml/min per 1.73 m 
Overall Survival Analysis
The unadjusted differences in overall survival in each propensity score-matched cohort are shown in Figure 4 . Over a median follow-up of 47 months (25th, 75th percentile, 24-77 months), more patients died after radical nephrectomy (760, 25.7%) than partial nephrectomy (472, 16.0%) in the primary propensity score-matched cohort. Similarly, more patients died after radical nephrectomy (212, 11.5%) than partial nephrectomy (83, 4.5%) among patients with normal or near-normal preoperative kidney function. These differences were consistent in propensity score-matched cohorts that included clinical tumor T stage as matching criteria. The hazard of death was significantly reduced in fully adjusted proportional hazards models performed in the primary propensity score-matched cohort (Hazard Ratio, 0.55; 95% CI, 0.49 to 0.62) and in the cohort of patients with normal or near-normal preoperative kidney function (Hazard Ratio, 0.52; 95% CI, 0.44 to 0.61) ( Table 3) .
DISCUSSION
The likelihood of decline in kidney function after kidney cancer surgery is an important consideration when treating patients with a renal mass. Previous reports have explored the decline in kidney function after kidney cancer surgery using administrative claims for ESRD or receipt of dialysis, 17 using laboratory results in clinical trials 18 or data from single institutions. In this study, we measured changes in kidney function after kidney cancer surgery using electronic health record data from the largest nation-wide integrated health care system in the United States. These data show that a decline in kidney function after kidney cancer surgery is relatively common. Nearly 8% of patients experienced incident stage 4 or higher CKD, and 14.2% of patients with normal or near-normal kidney function experienced incident stage 3b or higher CKD.
These data help establish and quantify the comparative effectiveness of partial nephrectomy versus radical nephrectomy in preserving kidney function in an era of increasing utilization of elective partial nephrectomy. To account for selection bias on the basis of observed characteristics, 16 we used propensity score matching and fitted multivariate proportional hazards and competing risk regression models. Our results suggest that receipt of partial nephrectomy was associated with a .60% reduction of the hazard of developing advanced (stage 4 or higher) CKD. For patients with normal or near-normal preoperative kidney function, partial nephrectomy offered an even greater 80% reduction in the hazard of eGFR decline to stage 3b or higher CKD. These data build on previous single institution reports documenting the role of partial nephrectomy in preserving kidney function. 19, 20 Although administrative data does not include direct measurements of kidney function, Miller et al. 17 and Sun et al. 21 both reported that partial nephrectomy was protective against incident claims for CKD or RRT in the Surveillance, Epidemiology, and End Results-Medicare data. Kidney function outcomes have also been measured as a secondary outcome in a prospective randomized, controlled trial. 18 In this trial, patients with normal preoperative creatinine levels treated with partial nephrectomy were less likely to reach a postoperative eGFR,60 ml/min per 1.73 m 2 (38.4% versus 58.7%) or a postoperative eGFR,30 ml/min per 1.73 m 2 (3.5% versus 6.6%) than those receiving radical nephrectomy. A growing number of reports have documented the safety of partial nephrectomy in older patients, 22, 23 and provide evidence for a survival benefit in older patients undergoing partial nephrectomy. 24 Our analysis of propensity score-matched cohorts also suggests a survival benefit for patients who receive a partial nephrectomy. Together, these studies support the contemporary use of partial nephrectomy in older patients and those with impaired preoperative kidney function when feasible.
This report also illustrates how patient age and preoperative kidney function can be used for preoperative counseling. Each 0.1 mg/dl increase in the preoperative serum creatinine concentration was associated with a 40% increase in the hazard of incident stage 4 or higher CKD, and a 90% increase in the hazard of stage 3b or higher CKD for patients with normal or near-normal preoperative kidney function. For every 10-year increase in age, the hazard of development of stage 4 or greater CKD increased 18%, and among patients with normal or near-normal kidney function, the hazard of developing stage 3b or greater CKD increased 64%. The association of age with decline in kidney function was particularly pronounced after radical nephrectomy, where 1.4%, 6.2%, 8.9%, and 15.1% of patients aged ,50, 50-60, 60-70, and older than 70 years, respectively, experienced stage 4 or greater CKD, suggesting a loss of renal reserve.
Our results suggest that surgically induced reductions in nephron mass may manifest differently than loss of kidney function associated with medical causes. One of the more striking findings of this study was that the majority (nearly 80%) of eGFR decline occurred within the first year of surgery. After reaching a new (postoperative) level of baseline function, few patients progressed to develop advanced CKD. In the full cohort, patients had a mean decline in postoperative eGFR of 0.41 ml/min per 1.73 m 2 per year (0.64% decline per year) after partial nephrectomy and an increase of 0.25 ml/min per 1.73 m 2 per year after radical nephrectomy (0.53% increase per year). In contrast, medical conditions have been associated with steeper downward trajectories in kidney function. 25 This is notable given the cohort's relatively low baseline preoperative kidney function, and the presence of comorbidities commonly associated with impaired kidney function. Our observation of stable kidney function is also similar to the long-term kidney function outcomes after partial nephrectomy from a large, single-institution series. 26 More generally, these findings raise the question of whether the decline in kidney function associated with a surgical reduction in nephron mass should be considered CKD-a controversy similar to that raised in the setting of living kidney donors. 27 In this study, patients that received a partial nephrectomy had a significantly reduced risk of mortality (30%-45% reduction) when compared with patients who received a radical nephrectomy. Partial nephrectomy has been associated with improved survival outcomes in many single institution series. In 2012, Tan et al. 24 also identified improved survival after partial nephrectomy among Medicare patients using an instrumental variable analysis. However, the only available randomized clinical trial comparing radical and partial nephrectomy did not demonstrate any difference in survival at a median follow-up of 9 years. 18 Most of the patients in this trial were healthy, with no chronic medical conditions and normal or near-normal preoperative kidney function. We have shown previously that patients who undergo partial nephrectomy in the VHA are generally younger, with better kidney function, compared with those who undergo radical nephrectomy. 16 Future research is required to determine if the survival difference seen among veterans receiving care in the VHA reflects residual selection bias, and if surgically induced kidney function loss is associated with other morbidities, such as cardiovascular disease.Our study has some notable strengths. Most importantly, we were able to determine the presence or absence of CKD at baseline and during followup using laboratory data rather than diagnosis codes, which may under-ascertain and/or misclassify CKD or CKD stage. Our study also has some limitations. Although we were able to adjust for numerous clinical characteristics, accounted for differential utilization of partial versus radical nephrectomy using propensity score matching, and considered the role of competing risks, some residual confounding is likely. Nevertheless, the point estimates and upper ends of the 95% CIs were well below unity. It is unlikely that residual confounding could change the qualitative results. These data were derived from the VHA population, which is older and almost entirely male. Veterans with cancer receiving care in the VHA are known to have lower performance status and higher rates of severe comorbidity. 28 Consequently, our results may not be fully generalizable to women, or younger, healthier patients. Despite these concerns, veterans treated in the VHA are an ideal population to evaluate kidney function outcomes after kidney surgery. Kidney cancer is twice as likely to occur in men, and more than half of patients diagnosed with kidney cancer are between 55 and 75 years of age. 29 Not surprisingly, kidney cancer is one of the most common cancers diagnosed among veterans enrolled in the VHA. 30 Outcomes for patients receiving cancer care in the VHA have been shown to be comparable or better than in the community. 28 Because the VHA maintains a national electronic health record and research data, the VHA is also uniquely positioned to assess kidney function over time in a nationally distributed "real world" setting. Partial nephrectomy was associated with a lower risk of developing clinically significant CKD than radical nephrectomy. Postoperative decline in kidney function occurs most commonly in the first 12 months after surgery and appears stable over time. Tumor stage, patient age, and preoperative kidney function are predictors of incident CKD after kidney cancer surgery.
CONCISE METHODS
The study was approved by the Veterans Affairs Palo Alto Health Care System Research and Development Committee and the Stanford University Institutional Review Board.
Analytic Cohort and Patient Characteristics
The VHA national utilization files include information for all veterans receiving VHA care. We identified 19,006 patients who had a radical or partial nephrectomy in the VHA from 2001 to 2013 (Supplemental Table 5 ). We excluded patients with more than one kidney cancer surgical code during the study cohort (n=957). Comorbidity was ascertained using the Romano adaptation of the Charlson-Deyo comorbidity score. 31 
Cancer-Specific Information
We extracted tumor-specific data from the Corporate Data Warehouse Oncology data when available using the 2010 TNM staging system. 
Pre-and Postoperative Measures of Kidney Function
We identified serum creatinine measurements using the Managerial Cost Accounting laboratory data file, including 117,763 preoperative serum creatinine measurements during the 12-month period before the surgery date. We excluded patients with no available preoperative serum creatinine values (n=1200) and those patients with two or more preoperative eGFR values ,30 ml/min per 1.73 m 2 or dialysis procedure codes (n=1453). We calculated the eGFR using the four-variable Modification of Diet in Renal Disease study equation. 32 We identified 440,582 postoperative serum creatinine measurements. We excluded serum creatinine measurements in the first 3 months after surgery in order to avoid detection of transient postoperative AKI. We excluded patients with no postoperative serum creatinine measurements (n=696), resulting in a total analytic cohort of 14,129 patients. To determine the risk of clinically significant CKD among patients with normal or near-normal kidney function preoperatively, we also performed a parallel analysis of 8089 patients with preoperative eGFR values $60 ml/min per 1.73 m 2 .
Propensity Score Matching
We constructed propensity score-matched cohorts to adjust for the previously described differences in characteristics between patients treated with partial and radical nephrectomy. 16 We included patient characteristics (age, sex, race/ethnicity, Charlson score, mean preoperative serum creatinine, and year of surgery) as matching variables. We then used a two-digit greedy matching algorithm resulting in a cohort of 5908 patients with a preoperative eGFR$30 ml/min per 1.73 m 2 and a parallel cohort of 3680 patients with a preoperative eGFR$60 ml/min per 1.73 m 2 . Separate propensity score-matched cohorts were also created for patients with available tumor information.
Kidney Function Outcomes
Our primary outcome was the time to incident clinically significant CKD, which we defined as the first eGFR,30 ml/min per 1.73 m 2 or 
Mortality and Competing Risk Regression
Patient survival was determined using the Veterans Affairs (VA) Vital Status File using deaths recorded before January 1, 2014. We defined overall survival as the time from the date of surgery to the date of death. We censored patient follow-up on January 1, 2014 for patients who were alive on or after the study end date. We fitted multivariable competing risk regression models using the Fine and Gray modification of proportional hazards regression models within the propensity score-matched cohorts. 33 
Statistical Analyses
Preoperative characteristics were compared between radical and partial nephrectomy groups using the Mann-Whitney test for continuous variables and the chi-squared test for categoric variables. We generated Kaplan-Meier product limit estimates to compare the unadjusted association of surgery type, preoperative kidney function, and tumor characteristics on kidney function outcomes. We fitted adjusted proportional hazards regression models to test patient and clinical factors associated with decline in kidney function outcomes in propensity score-matched cohorts. We included baseline serum creatinine concentrations in the proportional hazards models, instead of eGFR, to avoid the inclusion of age and race in multiple model parameters. All statistical analyses were conducted within the VA Informatics and Computing Infrastructure (VINCI) platform using SAS v9.4 (Cary, NC) and figures were generated using JMP Pro v13 (Cary, NC).
